Stock search

Ticker or company name

Charles River Laboratories

CRL · NYSE · Life Sciences Tools & Services

$335,52Down −2,45 (−0,72%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$16,2 bn
Div. yield
—
Year to date
+69,4%
52 weeks: $146,20$379,63

Ratio score

50/100
Ratio would watch

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

4 ✓ · 1 — · 4 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM403,031,337,9
Forward P/E29,5—29,5
PEGn/a—3,7
P/S4,12,56,6
EV/EBITDA82,122,329,9
P/FCF39,1—38,7
P/B5,03,35,4

Industry median — across 11 profitable companies in “Life Sciences Tools & Services” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 22 analysts

Buy
17
Hold
5
Sell
0

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20263,003,09Up +2,9%
Q2 20262,763,02Up +9,2%
Q1 20261,962,06Up +5,0%
Q4 20252,372,39Up +1,0%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue983 m1,00 bn996 m994 m1,00 bn1,03 bn984 m1,00 bn1,01 bn1,03 bn1,01 bn1,01 bn
EPS6,86−0,03−0,30−5,561,101,060,50−4,171,331,741,303,64
Margin34,0%−0,1%−1,5%−27,8%5,5%5,1%2,6%−21,3%7,0%9,2%7,4%18,6%
FCF207 m149 m−14,8 m58,6 m178 m169 m112 m83,7 m213 m154 m50,7 m143 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: purchases $7 338 (2 people), sales $52,1 m.

NameAmountSharesPrice
foster james c22 Oct 2026 · sale$8,41 m24 042$350,00
parisotto shannon m21 Oct 2026 · sale$742 5482 156$344,41
parisotto shannon m5 Oct 2026 · sale$302 580981$308,44
coleman glenn30 Sep 2026 · open-market purchase$2 97410$297,43
foster james c25 Aug 2026 · sale$10,1 m33 561$300,00
parisotto shannon m19 Aug 2026 · sale$599 7112 039$294,12
andrews nancy c18 Aug 2026 · sale$163 443573$285,24
girshick birgit11 Aug 2026 · sale$1,82 m6 500$279,90
parisotto shannon m11 Aug 2026 · sale$1,04 m3 714$279,66
foster james c10 Aug 2026 · sale$7,90 m28 733$275,00
knell michael gunnar6 Aug 2026 · sale$190 278736$258,53
knell michael gunnar6 Aug 2026 · sale$311 5291 205$258,53
knell michael gunnar6 Aug 2026 · sale$104 446404$258,53
knell michael gunnar6 Aug 2026 · sale$127 812482$265,17
knell michael gunnar6 Aug 2026 · sale$163 643620$263,94

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Life Sciences Tools & Services
Exchange
NYSE
Country
US
IPO date
23 Jun 2000

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
RVTYRevvity$148,8556would watch68,1+4,6%8,6%
TECHBio-Techne$72,7969would watch62,9+0,9%—
WSTWest Pharmaceutical Services$417,8083would consider45,5+12,6%18,8%
ILMNIllumina, Inc.$198,0075would consider33,6+5,8%19,7%
MTDMettler Toledo$1 727,2663would watch36,5+6,5%22,2%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.